In addition, 12 antigastric adenocarcinoma drugs were screened according to lncRNA signals associated with iron drop: ABT.263, AMG.706 (Motesanib), AP.24534, CCT007093, DMOG, imatinib, JNJ.26854165, JNK inhibitor VIII, KIN001.135 (benzimidazole-thiophene carbonitrile), lenalidomide, nilotinib, and AKT inhibitor VIII. The gene discussed is AKT1; the disease is adenocarcinoma.